SLP7111228
SLP7111228 is a SphK1 inhibitor. SLP7111228 reduces LPS-induced TNFα and IL-1β production. SLP7111228 can be used in neuroinflammatory diseases research[1].
Product Specifications
CAS Number
1449765-82-5
UNSPSC
12352005
Target
SphK
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
CCCCCCCCC(C=C1)=CC=C1C2=NOC(C[C@H]3N(CCC3)C(N)=N)=N2
Molecular Formula
C22H33N5O
Molecular Weight
383.53
References & Citations
[1]Standoli S, et al. Sphingosine Kinases at the Intersection of Pro-Inflammatory LPS and Anti-Inflammatory Endocannabinoid Signaling in BV2 Mouse Microglia Cells. Int J Mol Sci. 2023 May 9;24 (10) :8508.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
SphK1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY401167 100 µg
Miz1 (ZBTB17) (NM_003443) Human Over-expression Lysate
Sign In for Pricing
View Details 
